SAEs · NSTI
Intravenous immunoglobulin showed no clear difference in serious adverse events (SAE) compared with placebo (low certainty).
1 finding from 1 review
SAEs · NSTI
It is very uncertain whether moxifloxacin changes serious adverse events (SAE) compared with amoxicillin‐clavulanate (very low certainty).
1 finding from 1 review
SAEs · NSTI
It is very uncertain whether AB103 changes serious adverse events (SAE) compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · minimally verbal children with autism spectrum disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · autumn asthma exacerbations in children
Omalizumab showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
A boost of inhaled corticosteroids showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
Leukotriene receptor antagonist showed no clear difference in adverse events compared with usual care (high certainty).
1 finding from 1 review
Serious adverse events ( · children with either displaced distal radius fracture with intact or displaced ulna fracture (both‐bone fracture), or minimally displaced…
1 finding from 1 review
Adverse events3 · participants with chronic prostatitis/chronic pelvic pain syndrome
Circumcision plus usual care showed no clear difference in adverse events3 compared with waiting list plus usual care (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Acupuncture showed no clear difference in adverse events compared with sham procedure (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Extracorporeal shockwave therapy showed no clear difference in adverse events compared with control procedure (low certainty).
1 finding from 1 review
Adverse events · treating chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Incidence of adverse events · first aid in patients with acute oral poisoning (anti‐inflammatory drugs, analgesics or psychotropic drugs)
It is very uncertain whether SDAC changes incidence of adverse events compared with syrup of ipecac (very low certainty).
1 finding from 1 review
Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events attributed to GM-CSF typically bone pain, nausea, fever and headache; not reported as serious; reporting poor and inconsistent (SoF comments cell, not GRADE-rated)
8 studies
GRADE not reported
Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events attributed to KGF were typically oral-related or skin-related; mostly mild to moderate with very few serious events; reporting poor and inconsistent, not appropriate to meta-analyse (SoF comments cell,…
16 studies
GRADE not reported
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
1 finding from 1 review
In one study, one participant (<1%) in the paracetamol group experienced drug hypersensitivity (a 'red, blotchy and itchy rash') that resolved without treatment within 1 week (Bradley 2007 / McAlinden 2005); 1 RCT;…
1 study
Very low
Adverse events · Adults with cancer receiving treatment
1 finding from 1 review
Adverse events · Adults receiving chemotherapy alone for colorectal cancer
1 finding from 1 review
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review